Diagnosticos Da America SA operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Diagnosticos Da America SA with three other
pharmaceutical manufacturers in Latin America:
Fleury SA
(2018
sales of 2.66 billion Brazilian Reals [US$619.94 million]
of which 84%
was Diagnostic Medicine),
Hypera SA
(3.72 billion Brazilian Reals [US$866.53 million]
), and
Genomma Lab Internacional Sab De Cv
which is
based in Mexico
(11.79 billion Mexican Pesos [US$636.07 million]
of which 103%
was PC).
Sales Analysis.
Diagnosticos Da America SA reported sales of 3.93 billion Brazilian Reals (US$915.20 million)
for the
year ending
December of 2018.
This
represents
an
increase of 15.7%
versus 2017, when the company's sales were 3.40 billion Brazilian Reals.
Sales at Diagnosticos Da America SA have increased during each of the previous five years
(and since 2013, sales have increased a total of 58%).